• SENSEX 81,463.09
    -721.08 (--0.88%)
  • BANKNIFTY 56,528.90
    -537.15 (--0.94%)
  • Authum Invest
    2,250.00 985.45(%)
  • Indian Energy Ex
    149.45 244.35(%)
  • Vimta Labs
    598.90 598.90(%)
  • Bharti Airtel
    1,952.40 2,045.50(%)
  • Force Motors
    16,488.00 6,128.55(%)
  • Bajaj Finance
    897.65 642.61(%)
  • Anant Raj
    606.00 947.25(%)
  • Jayaswal Neco
    40.05 26.06(%)
  • Sharda Cropchem
    1,090.25 1,090.25(%)
  • Infosys
    1,511.35 1,307.10(%)
  • Olectra Greentec
    1,460.00 973.65(%)
  • Tata Motors
    685.00 542.55(%)
  • Eternal Ltd
    306.25 189.60(%)
  • Trent
    5,033.80 4,491.75(%)
  • Reliance Industr
    1,384.50 1,115.55(%)
  • Waaree Energies
    3,171.00 1,808.65(%)
  • Phoenix Mills
    1,545.00 1,965.00(%)
  • Kajaria Ceramics
    1,151.00 745.00(%)
  • Adani Green
    972.75 758.00(%)
  • Cipla
    1,553.00 1,702.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ajanta Pharma Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 13504.0
  • ISIN : INE031B01049
2,784.30 -12 (-0.43%)
  • As on 27 Jul 2025 (EOD)

  • Today’s Low

    2,762.00

  • Today’s High

    2,818.30

  • Open

    2,818.30

  • Perv Close

    2,796.40

  • 52W Low

    2,327.30

  • 52W High

    3,485.00

Key Indicators

  • P/E(TTM)

    38.35

  • Mar.Cap (₹Cr.)

    34,779.28

  • Div & Yield %

    1.01

  • Book Value(₹)

    290.22

  • Debt-Equity Ratio

    -0.43

  • AGM Date

    25-Jul-2025

  • EPS

    72.53

  • P/E Ratio

    38.35

Financials Ratios

  • Debt-Equity Ratio

    0.01

  • Mar.Cap (₹Cr.)

    34,779.28

  • RONW (%)

    23.47

  • ROCE (%)

    31.59

Score Board

  • Equity (₹ in Cr.)

    24.98

  • BV (₹)

    290.20

  • Sales( ₹ in Cr.)

    4,322.04

  • NP (in Cr.)

    906.01

  • NP Var(%)

    14.0

  • Div%

    1400.0

  • CPS (₹)

    83.70

  • EPS (₹)

    72.50

  • Traded Value (₹ in Lakhs)

    34,741.80

  • 52 Week High

    3,485.00

  • 52 Week Low

    2,327.30

  • Price BSE

    2781.0

  • Price NSE

    2,784.00

  • Market Capital( in Cr.)

    34,741.80

  • P/C Ratio

    33.20

  • P/E Ratio

    38.30

  • Price Vs.BV

    72.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 4,322.04 3,971.12 3,411.27 3,140.64 2,718.59 2,196.42
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 4,322.04 3,971.12 3,411.27 3,140.64 2,718.59 2,196.42
Other Income 119.87 116.48 132.75 139.73 103.57 184.20
Stock Adjustments 18.58 22.17 21.99 56.60 74.60 -9.02
Total Income 4,460.49 4,109.77 3,566.01 3,336.97 2,896.76 2,371.60
EXPENDITURE :            
Raw Materials 1,030.60 1,101.59 1,027.40 889.16 804.68 654.95
Power and Fuel Cost 70.22 66.44 65.53 54.09 43.42 38.56
Employee Cost 1,010.90 834.16 720.41 585.87 498.11 437.82
Other Manufacturing Expenses 198.94 168.11 185.50 169.95 119.25 124.80
Selling and Administration Expenses 695.46 587.02 602.95 512.46 324.31 308.60
Miscellaneous Expenses 129.78 116.54 132.19 94.82 86.51 93.81
Employee Benefit Expenses 1,010.90 834.16 720.41 585.87 498.11 437.82
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 3,135.90 2,873.86 2,733.98 2,306.35 1,876.28 1,658.54
Operating Profit 1,324.59 1,235.91 832.03 1,030.62 1,020.48 713.06
Interest 4.60 6.80 5.23 9.12 6.90 9.10
Gross Profit 1,319.99 1,229.11 826.80 1,021.50 1,013.58 703.96
Depreciation 139.93 132.16 126.95 120.96 111.49 91.29
Profit Before Tax 1,180.06 1,096.95 699.85 900.54 902.09 612.67
Current Tax 258.03 280.56 141.08 171.17 216.68 168.09
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 5.14 9.15 0.05 9.51 9.77 3.45
Reported Net Profit 916.89 807.24 558.72 719.86 675.64 441.13
Extraordinary Items 10.88 11.11 12.87 -0.62 2.91 -2.89
Adjusted Net Profit 906.01 796.13 545.85 720.48 672.73 444.02
Adjustment below Net Profit -213.11 -0.92 -74.72 -68.50 -32.42 -3.85
P & L Balance brought forward 3,253.44 3,089.29 2,694.98 2,125.83 1,565.51 1,244.15
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 349.75 642.17 89.69 82.21 82.90 115.93
P & L Balance carried down 3,607.47 3,253.44 3,089.29 2,694.98 2,125.83 1,565.50
Dividend 349.75 642.17 89.69 82.21 82.90 113.44
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 1,400.00 2,550.00 350.00 475.00 475.00 650.00
Dividend Per Share(Rs) 28.00 51.00 7.00 9.50 9.50 13.00
Earnings Per Share-Unit Curr 73.15 63.89 44.22 83.85 77.70 50.30
Earnings Per Share(Adj)-Unit Curr 73.15 63.89 44.22 55.90 51.80 33.53
Book Value 289.21 270.17 256.94 369.15 331.80 280.65
Book Value(Adj)-Unit Curr 289.21 270.17 256.94 246.10 221.20 187.10

Shareholding Pattern

  • Promoter Group

    66.26%

  • Public Share Holding

    33.74%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 12,588,393 10.08 12,588,393 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 70,175,384 56.18 70,175,384 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 82,763,777 66.26 82,763,777 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 6,715 0.01 6,715 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 55 0.00 55 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 11,063,482 8.86 11,063,482 308
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,508,589 2.01 2,508,589 13
Mutual Funds / UTI 18,391,936 14.72 18,391,936 28
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 960,946 0.77 960,946 20
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 32,931,723 26.36 32,931,723 371
2] Non Institution
Bodies Corporate 274,902 0.22 273,777 527
Clearing Members 1,141 0.00 1,141 6
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 382,102 0.31 382,102 2,580
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 171,256 0.14 171,256 1,211
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 853,138 0.68 853,138 5
Individuals holding nominal share capital up to Rs. 1 lakh 7,373,646 5.90 7,212,697 64,105
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 600 0.00 600 5
Others 135,121 0.11 135,121 3
Sub Total 9,216,599 7.38 9,054,525 68,503
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 124,912,099 100.00 124,750,025 68,882

Company Background

Ajanta Pharma LtdPharmaceuticals - Indian - Formulations

  • Ajanta Pharma Ltd
  • BSE Code : 13504.0
  • ISIN : INE031B01049

  • Incorporation Year

    1979

  • Registered Office

    Ajanta House
    Charkop Kandivli (W), Mumbai,
    Maharashtra-400067

  • Telephone

    91-22-66061000/1204/1203

  • FAX

    91-22-66061200/1300

  • Chairman

    Mannalal B Agrawal

  • Managing Director

    Yogesh Agrawal

  • Company Secretary

    Gaurang Shah

  • Auditor

    B S R & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Ajanta Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ajanta Pharma 2,781.30 4,441.91 4,322.04 37.89 32.78
Abbott India 33,771.20 6,684.73 6,409.15 50.74 44.95
Astrazeneca Phar 8,832.65 1,756.92 1,716.29 190.77 32.94
P & G Health Ltd 5,831.90 1,166.89 1,151.26 38.54 39.76
Glaxosmi. Pharma 3,154.75 3,866.05 3,723.49 58.15 58.72
Cipla 1,531.10 20,029.57 19,044.85 23.98 21.40
Amrutanjan Healt 679.00 437.58 421.23 38.62 20.84
Fermenta Biotec. 375.35 442.21 430.53 16.34 17.61
Guj. Themis Bio. 363.35 174.19 169.82 81.10 44.82
Bliss GVS Pharma 153.45 703.42 667.20 23.46 9.16
Ambalal Sarabhai 32.88 19.33 4.04 30.44 2.10